U.S. stock-index futures Tuesday morning saw early gains deepen following a report of a potential treatment for COVID-19 that has proved successful in early trials. A report from the BBC and other outlets say that Dexamethasone, a cheap and widely available steroid, is being seen as having had success in low doses to improve outcomes for hospitalized patients who are suffering serious symptoms from the illness derived from the novel strain of coronavirus . The BBC report was from a study led by a team from Oxford University, which included 2,000 hospital patients who were given the steroid and were compared with more than 4,000 who didn't get the drug. The report indicated that for "patients on ventilators it cut death risk from 40% to 28%," and for "patients needing oxygen it cut death risk from 25% to 20%." Futures for the Dow Jones Industrial Average DJIA,
